Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Immunovant, Inc.
Business Segments
Business Segments
Business Segments
8 metrics
R&D
Acquired in-process research and development
Personnel-related general and administrative
Other general and administrative
Interest Income (Expense), Nonoperating
Other segment items
Net loss
Share-Based Payment Arrangement, Expense
Watchlist
Screener
Filings
Earnings
Charts